glp-1 side effects risks Common Weight-loss A monthly GLP-1 dose could

While GLP-1 medications do not directly cause frequent urination, several indirect mechanisms may explain why some individuals notice changes in their urinary patterns after starting treatment

The ASA emphasized an individualized, risk-based approach, particularly for patients in the initial dose-escalation phase (typically 48 wk after initiating therapy) or those experiencing severe gastrointestinal symptoms.The BJA, in contrast, advocates a more flexible and individualized management strategy

Some patients report better sleep quality after starting treatment

Traditionally, patients are seen by a provider, have an accurate health history taken, any necessary exams or labs are performed, then, only if its the best fit, that provider will prescribe needed medications